BRPI0820068A2 - Composição para nutrição humana e/ou animal, usos derivados e leveduras - Google Patents

Composição para nutrição humana e/ou animal, usos derivados e leveduras

Info

Publication number
BRPI0820068A2
BRPI0820068A2 BRPI0820068-8A BRPI0820068A BRPI0820068A2 BR PI0820068 A2 BRPI0820068 A2 BR PI0820068A2 BR PI0820068 A BRPI0820068 A BR PI0820068A BR PI0820068 A2 BRPI0820068 A2 BR PI0820068A2
Authority
BR
Brazil
Prior art keywords
yeast
human
composition
animal nutrition
derived
Prior art date
Application number
BRPI0820068-8A
Other languages
English (en)
Inventor
Jean-Luc Simon
Georges Pignede
Pascal Vandekerckove
Daniel Poulain
Pierre Desreumaux
Arlette Darfeuille-Michaud
Adeline Sivignon
Original Assignee
Lesaffre & Cie
Université Du Droit Et De La Santé Lille 2
Université D Auvergne Clermont 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0801342A external-priority patent/FR2928652B1/fr
Application filed by Lesaffre & Cie, Université Du Droit Et De La Santé Lille 2, Université D Auvergne Clermont 1 filed Critical Lesaffre & Cie
Publication of BRPI0820068A2 publication Critical patent/BRPI0820068A2/pt
Publication of BRPI0820068B1 publication Critical patent/BRPI0820068B1/pt
Publication of BRPI0820068B8 publication Critical patent/BRPI0820068B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • C12N1/185Saccharomyces isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14Yeasts or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/85Saccharomyces
    • C12R2001/865Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
BRPI0820068A 2007-12-26 2008-12-12 uso de cepa de levedura e/ou de uma composição compreendendo cepa de levedura para preparação de um medicamento BRPI0820068B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0760377 2007-12-26
FR0760377 2007-12-26
FR0801342 2008-03-12
FR0801342A FR2928652B1 (fr) 2008-03-12 2008-03-12 Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
PCT/FR2008/001729 WO2009103884A2 (fr) 2007-12-26 2008-12-12 Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures

Publications (3)

Publication Number Publication Date
BRPI0820068A2 true BRPI0820068A2 (pt) 2015-09-01
BRPI0820068B1 BRPI0820068B1 (pt) 2020-03-17
BRPI0820068B8 BRPI0820068B8 (pt) 2021-07-27

Family

ID=40985983

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0820068A BRPI0820068B8 (pt) 2007-12-26 2008-12-12 uso de cepa de levedura e/ou de uma composição compreendendo cepa de levedura para preparação de um medicamento

Country Status (24)

Country Link
US (1) US8476058B2 (pt)
EP (1) EP2227539B1 (pt)
JP (1) JP5497661B2 (pt)
KR (1) KR101654537B1 (pt)
CN (1) CN101918536B (pt)
AU (1) AU2008351156B2 (pt)
BR (1) BRPI0820068B8 (pt)
CA (1) CA2709850C (pt)
DK (1) DK2227539T3 (pt)
ES (1) ES2649914T3 (pt)
HR (1) HRP20171632T1 (pt)
HU (1) HUE034628T2 (pt)
IL (1) IL206110A (pt)
LT (1) LT2227539T (pt)
MX (1) MX2010007011A (pt)
MY (1) MY159379A (pt)
NO (1) NO2227539T3 (pt)
NZ (1) NZ586417A (pt)
PL (1) PL2227539T3 (pt)
RU (1) RU2490324C2 (pt)
SI (1) SI2227539T1 (pt)
TN (1) TN2010000239A1 (pt)
WO (1) WO2009103884A2 (pt)
ZA (1) ZA201003978B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876798A1 (fr) * 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
SI2227539T1 (en) 2007-12-26 2018-03-30 Lesaffre Et Compagnie A composition for human and / or animal consumption, its use and yeast
FR2949043B1 (fr) * 2009-08-17 2013-05-17 Lesaffre & Cie Pate boulangere fermentee tolerante a l'appret
CN103313718B (zh) * 2011-03-04 2016-09-14 狮王株式会社 生长激素分泌促进剂
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
WO2015061798A2 (en) * 2013-10-25 2015-04-30 R.F. Technology Consultants, Inc. Compositions and methods comprising yeast organisms and lipid extracts thereof
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
KR101837160B1 (ko) 2016-07-20 2018-03-09 서울대학교산학협력단 신균주 bt-sjp kctc12726bp 및 이의 용도
EP3524254A4 (en) * 2016-09-14 2020-11-11 Tes Holdings Co., Ltd. LIN28A ACTIVATOR AND USE OF IT
US11523625B2 (en) 2017-08-07 2022-12-13 Techmix, Llc Feed supplement bolus with active yeast
CN109536370A (zh) * 2018-12-10 2019-03-29 浙江华康药业股份有限公司 一种体外发酵糖醇益生功能评价装置及方法
FR3089788B1 (fr) 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
FR3090318A1 (fr) 2018-12-19 2020-06-26 Lesaffre Et Compagnie Souche Saccharomyces Cerevisiae var boulardii en Santé Orale
FR3096891B1 (fr) 2019-06-04 2022-05-13 Lesaffre & Cie Composition pour la prevention de la cystite simple et/ou recidivante
CN112273657A (zh) * 2019-07-22 2021-01-29 安琪酵母股份有限公司 用于预防或改善过敏性疾病的益生菌组合物、制法和应用
KR102275115B1 (ko) * 2019-10-16 2021-07-07 한국식품연구원 프로바이오틱 활성을 갖는 사카로마이세스 세레비지애 보울라디­03 신균주 및 이의 용도
FR3120789B1 (fr) 2021-03-16 2024-01-19 Lesaffre & Cie Inhibiteurs glycosidiques de levure
AU2022303106A1 (en) 2021-06-30 2024-02-01 Ab Mauri (Uk) Ltd Physiologically acceptable yeast compositions and uses thereof
FR3134581A1 (fr) * 2022-04-15 2023-10-20 Lesaffre Et Compagnie Levure Saccharomyces cerevisiae et son utilisation pour améliorer la santé intestinale des animaux de compagnie.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
RU2233320C2 (ru) * 2001-02-13 2004-07-27 Гриневич Владимир Борисович Способ получения биологически активного препарата, биологически активная добавка (бад) к пище пребиотического действия, приводящая к коррекции (нивелированию) метаболического синдрома и лекарственный препарат для регуляции микробиоценоза желудочно-кишечного тракта
US20080226614A1 (en) 2004-08-23 2008-09-18 Krishna Murthy Ella Eukaryotic Based Synergistic Formulation for Gastro-Intestinal Disorders
US7799328B2 (en) 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
US7498367B2 (en) * 2005-02-21 2009-03-03 Kerr Corporation Acid-tolerant dental composition
FR2928652B1 (fr) 2008-03-12 2013-11-15 Lesaffre & Cie Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
SI2227539T1 (en) 2007-12-26 2018-03-30 Lesaffre Et Compagnie A composition for human and / or animal consumption, its use and yeast

Also Published As

Publication number Publication date
ES2649914T3 (es) 2018-01-16
US20100303778A1 (en) 2010-12-02
NZ586417A (en) 2012-07-27
CA2709850C (fr) 2018-03-20
HRP20171632T1 (hr) 2017-12-15
RU2010131018A (ru) 2012-02-10
CN101918536B (zh) 2013-07-03
JP2011509651A (ja) 2011-03-31
IL206110A0 (en) 2010-11-30
EP2227539A2 (fr) 2010-09-15
AU2008351156A1 (en) 2009-08-27
LT2227539T (lt) 2017-11-27
NO2227539T3 (pt) 2018-01-06
TN2010000239A1 (fr) 2011-11-11
ZA201003978B (en) 2012-02-29
CN101918536A (zh) 2010-12-15
US8476058B2 (en) 2013-07-02
KR20110066118A (ko) 2011-06-16
HUE034628T2 (hu) 2018-02-28
BRPI0820068B1 (pt) 2020-03-17
JP5497661B2 (ja) 2014-05-21
CA2709850A1 (fr) 2009-08-27
MY159379A (en) 2016-12-30
AU2008351156B2 (en) 2013-10-17
MX2010007011A (es) 2010-10-13
DK2227539T3 (da) 2017-11-13
EP2227539B1 (fr) 2017-08-09
KR101654537B1 (ko) 2016-09-06
PL2227539T3 (pl) 2018-01-31
WO2009103884A2 (fr) 2009-08-27
BRPI0820068B8 (pt) 2021-07-27
RU2490324C2 (ru) 2013-08-20
SI2227539T1 (en) 2018-03-30
IL206110A (en) 2013-07-31
WO2009103884A3 (fr) 2009-12-17

Similar Documents

Publication Publication Date Title
BRPI0820068A2 (pt) Composição para nutrição humana e/ou animal, usos derivados e leveduras
BRPI0920698A2 (pt) Composições da proteína do soro do leite, métodos e usos
BRPI0923855A2 (pt) Ácido lipóico, e, composição de ração de animal de estimação.
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
BRPI0922043A2 (pt) composições compreendendo um aril pirazol e/ou formamidina, métodos e usos das mesmas
GB0804957D0 (en) Composition for hair, skin and nail health maintenance
BRPI0819714A2 (pt) Formulações de proteína e métodos de produção das mesmas.
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI0913447A2 (pt) composição de éster, e, composição para cuidado pessoal.
BRPI0716439A2 (pt) formulaÇÕes de flibanserina e mÉtodo para fabricaÇço das mesmas.
BRPI1012340A8 (pt) proteínas de ligação específica e usos das mesmas
BRPI0820568A2 (pt) Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
BR112014010186A2 (pt) formulação farmacêutica estável, kit, composição farmacêutica, método para preparar uma formulação farmacêutica, e, método para tratar um humano ou animal
BRPI0911656A2 (pt) formulações de nanopartículas e usos das mesmas
BRPI0919403A2 (pt) polipeptídeos modificados de eritropoetina animal e seus usos
BRPI0916036B8 (pt) método cosmético para tratar a perspiração humana, composição e composição sólida anidra
BRPI0813897A2 (pt) Uso de uma substância, composição cosmética ou dermo-cosmética ou neutracêutica, composição farmacêutica, método de cuidado cosmético, e, seqüência de nucleotídeos.
BRPI0821858A2 (pt) Composto, composição para cuidado oral, e, método
BRPI1012066A2 (pt) composição para o cuidado oral , e, métodos para preparar a composição para o cuidado oral e para administrar um composto de zinco a um indivíduo animal ou humano em necessidade do mesmo
BRPI0818690A2 (pt) Derivados de quinazolinediona, sua preparação e seus usos terapêuticos.
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
BRPI0907561A2 (pt) Materiais e métodos para aperfeiçoamento da saúde de camarões
BRPI0820850A2 (pt) Formulação de ração para animais de estimação
BRPI0916043A2 (pt) composição farmacêutica e alimento funcional para prevenir ou tratar câncer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C12N 1/18; A61K 36/064; A23L 1/30.

Ipc: A61K 36/064 (2006.01), A23L 33/14 (2016.01), C12R

Ipc: A61K 36/064 (2006.01), A23L 33/14 (2016.01), C12R

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/12/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO